Weymouth Design Wins Best Biotechnology/Pharmaceuticals Website at the 2005 MITX Awards
Nabi Biopharmaceuticals Website Recognized as Best in Interactive Technologies
BOSTON, MA (NOVEMBER 8, 2005) -- Weymouth Design's work on Nabi Biopharmaceuticals' website redesign (www.nabi.com) has been selected as the winner in the category of Biotechnology/ Pharmaceuticals by the 2005 MITX Awards. The annual MITX Awards is the largest awards competition in the country that recognizes achievements in the development and implementation of interactive technologies.
Nabi Biopharmaceuticals' redesigned site is a crucial vehicle for continually relaying key developments to constituents including patients, physicians, media and investors. "By clearly articulating the essence of the Nabi Biopharmaceuticals' brand, leveraging cutting-edge technology, design, photography, animation and video, we believe that the website provides a strong and lasting impression of Nabi Biopharmaceuticals," said Tom Kraft, a Director of Interactive Media for Weymouth Design.
Weymouth Design, in partnership with Feinstein Kean Healthcare, redesigned the website. Weymouth Design provided creative concepts, art direction, interface design and development, audio and video production and post production, photography, rich-media, animation, application development and content management. Feinstein Kean Healthcare, a life science communications consulting firm, provided content, writing and strategic direction.
About Weymouth Design
Weymouth Design has expertise in all aspects of corporate communications and corporate and brand identity. The firm has experience working with all types of media including print, digital media, film and video. Founded in 1973, the firm is based in Boston, MA with offices in San Francisco, CA.
Contact: Graham Schelter
gschelter@weymouthdesign.com
Phone : 617.259.1421
About Feinstein Kean Healthcare
Feinstein Kean Healthcare, a wholly owned subsidiary of Ogilvy Public Relations Worldwide, specializes in integrated corporate and product communications for life sciences and healthcare companies and organizations. The firm's portfolio of clients includes the full spectrum of emerging therapeutic and technology platform companies; four of the world's five largest pharmaceutical companies; government agencies; and policy organizations. For more information about FKH, visit: www.fkhealth.com.
Contact: Francesca T. DeVellis
Sr. Vice President
Francesca.DeVellis@fkhealth.com
Feinstein Kean Healthcare
Phone : 617.577.8110